跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Efamed Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Efamed Plus
Approved
STANDARD
Efamed Plus
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
dee7db55b2d896a3
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
dee7db55b2d896a3
Drug Approval Philippines Name
Efamed Plus
Product Name
Efamed Plus
Registration Number
DR-XY27288
Brand Name
Efamed Plus
Generic Name
Guaifenesin + Salbutamol
Dosage Form
Syrup
Dosage Strength
50mg/ 1mg per 5mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
Medhaus Pharma, Inc.
Issuance Date
28 December 2021
Expiry Date
08 February 2027
Pharmacologic Category
Expectorant/Selective beta-2-adrenoreceptor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
dee7db55b2d896a3
Type
Standard
Back to Philippines FDA Approvals